217 related articles for article (PubMed ID: 7563597)
1. [Secondary myeloid/natural killer cell acute leukemia appeared in multiple myeloma treated with melphalan].
Kaya H; Nakamura S; Yamazaki H; Kumabashiri I; Ohtake S; Matsuda T
Rinsho Ketsueki; 1995 Jul; 36(7):682-6. PubMed ID: 7563597
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia complicating multiple myeloma: a case successfully treated with etoposide, thioguanine, and cytarabine.
Erikci AA; Ozturk A; Tekgunduz E; Sayan O
Clin Lymphoma Myeloma; 2009 Aug; 9(4):E14-5. PubMed ID: 19717372
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of secondary erythroleukemia with androgen].
Ogata K; Futaki M; Inokuchi K; Gomi S; Ohki I; Kuwabara T; Dan KZ; Kuriya S; Nomura T; Shinohara T
Rinsho Ketsueki; 1989 Jul; 30(7):1079-83. PubMed ID: 2810794
[TBL] [Abstract][Full Text] [Related]
4. [Four cases of therapy-related leukemia in multiple myeloma].
Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
[TBL] [Abstract][Full Text] [Related]
5. [Multiple myeloma following chronic neutrophilia terminated with acute monocytic leukemia (AML, M 5 b)].
Abe K; Imamura N; Mtasiwa DM; Inada T; Fujimura K; Kuramoto A
Rinsho Ketsueki; 1989 Jun; 30(6):910-4. PubMed ID: 2795904
[TBL] [Abstract][Full Text] [Related]
6. [Multiple myeloma complicated with Takotsubo cardiomyopathy].
Mitsumori T; Nakajima K; Nozaki Y; Hamanaka S; Nagashima T; Kirito K; Iwao N; Komatsu N
Rinsho Ketsueki; 2010 Apr; 51(4):291-6. PubMed ID: 20467228
[TBL] [Abstract][Full Text] [Related]
7. [Complete remission with MEC regimen of acute myeloid leukemia (M4) secondary to 5-year treatment of non-Hodgkin lymphoma].
Satoh Y; Sakuma A; Tuboi I; Hirano H; Yamazaki T; Ashiya M; Kura Y; Irie T; Sawada U; Takeuchi J
Rinsho Ketsueki; 1992 Nov; 33(11):1730-5. PubMed ID: 1281892
[TBL] [Abstract][Full Text] [Related]
8. Acute leukemia of plasmablastic type as terminal phase of multiple myeloma.
Piccinini L; Artusi T; Bonacorsi G; Arigliano V
Haematologica; 2002 Feb; 87(2):EIM04. PubMed ID: 11836178
[No Abstract] [Full Text] [Related]
9. [Multiple myeloma of the IgD-lambda type invading CNS].
Kitamura K; Takeuchi J; Kanbe E; Oka H; Saiki M; Aikawa S; Kura Y; Hatta Y; Yamazaki T; Ito T; Sawada U; Horie T
Rinsho Ketsueki; 2004 Oct; 45(10):1124-8. PubMed ID: 15553049
[TBL] [Abstract][Full Text] [Related]
10. Melphalan-prednisone versus alternating combination VAD/MP or VND/MP as primary therapy for multiple myeloma: final analysis of a randomized clinical study.
Cavo M; Benni M; Ronconi S; Fiacchini M; Gozzetti A; Zamagni E; Cellini C; Tosi P; Baccarani M; Tura S;
Haematologica; 2002 Sep; 87(9):934-42. PubMed ID: 12217805
[TBL] [Abstract][Full Text] [Related]
11. [Multiple myeloma preceding myelodysplastic syndrome with eosinophilia and der (1;7)].
Matano S; Kobayashi K; Nakamura S; Yoshida T
Rinsho Ketsueki; 1994 Nov; 35(11):1310-4. PubMed ID: 7823398
[TBL] [Abstract][Full Text] [Related]
12. Dexamethasone, paclitaxel, etoposide, cyclophosphamide (d-TEC) and G-CSF for stem cell mobilisation in multiple myeloma.
Bilgrami S; Bona RD; Edwards RL; Li Z; Naqvi B; Shaikh A; Furlong F; Fox J; Clive J; Tutschka PJ
Bone Marrow Transplant; 2001 Jul; 28(2):137-43. PubMed ID: 11509931
[TBL] [Abstract][Full Text] [Related]
13. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
[TBL] [Abstract][Full Text] [Related]
14. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
15. [Complete remission achieved by L-asparaginase, vincristine and prednisolone (LVP) therapy in secondary leukemia (M5a type) with an MLL gene rearrangement].
Tomita N; Fujita H; Koharazawa H; Maruta A; Kodama F; Yamamoto T; Kobayashi S; Okubo T
Rinsho Ketsueki; 1997 Feb; 38(2):135-41. PubMed ID: 9059068
[TBL] [Abstract][Full Text] [Related]
16. [A myeloma (IgG-kappa) terminating in acute myelogenous leukemia].
Fujii H; Yashige H; Taniwaki M; Urata Y; Kuzuyama Y; Kitagawa Y; Horishi M; Suyama Y; Miyoshi M
Gan No Rinsho; 1990 Apr; 36(5):645-50. PubMed ID: 2109137
[TBL] [Abstract][Full Text] [Related]
17. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
Yeh YA; Pappas AA; Flick JT; Butch AW
Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
[TBL] [Abstract][Full Text] [Related]
18. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
19. [Acute myelomonocytic leukemia occurred after multiple myeloma treated: a case report].
Wang TY; Huang XO; Xu CG; Chen XC; Wang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):347-9. PubMed ID: 17441363
[TBL] [Abstract][Full Text] [Related]
20. [Multiple myeloma and acute leukemia. Simultaneous evolution of plasmacyte and myelomonocytic clones].
Renoux M; Bernard JF; Bezeau A; Amar M; Boivin P
Sem Hop; 1978 Sep 18-25; 54(25-28):809-13. PubMed ID: 214859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
